FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248833643> ?p ?o ?g. }

• W4248833643 endingPage "53" @default.
• W4248833643 startingPage "33" @default.
• W4248833643 abstract "Type 2 diabetes (T2D) is the most common form of diabetes, a metabolic disorder characterized by hyperglycemia resulting from defects in insulin action, insulin secretion, or both. Early diagnosis of T2D and the high-risk category of pre-diabetes may help reduce the associated public health and clinical burden. Available diagnostic strategies include fasting plasma glucose, oral glucose tolerance test, and casual plasma glucose in the presence of symptoms of hyperglycemia. Potential use of hemoglobin A1c as part of the strategy for screening and diagnosis has been recently proposed. Those with risk factors for T2D should be targeted including patients with overweight/obesity, those with family history of T2D, those aged 45 years and older, race/ethnic minorities (such as Native Americans, African Americans, Latinos, and Asian Americans), women with history of gestational diabetes, and those with metabolic syndrome abnormalities (high blood pressure, low HDL cholesterol, and high triglycerides). Lifestyle modification (i.e., weight loss through diet and increased physical activity) has proven effective in reducing incident T2D in high-risk groups. Prevention trials using pharmacological therapy (metformin, α-glucosidase inhibitors, or thiazolidinediones) have also reported a significant lowering of the incidence of T2D. As a chronic condition, T2D requires continuous care to prevent damage to various organs, including the eyes, kidney, nervous system, and cardiovascular system. Appropriate glycemic control, blood pressure and lipid management, nutrition and physical activity, taking into account functional status and comorbidities, are needed to prevent microvascular and macrovascular complications. A variety of oral antihyperglycemic agents, which target different mechanisms in the pathogenesis of T2D, are as follows: insulin sensitizers, insulin secretagogues, α-glucosidase inhibitors, and the new dipeptidyl peptidase (DPP)-IV inhibitors. Injectable agents for the treatment of insulin-deficient T2D include traditional insulin preparations, newer insulin analogs, amylin, and incretin mimetics. Additional aspects of T2D management in the older adult include the assessment of geriatric syndromes and psychosocial screening. Efforts to improve T2D care following recommended guidelines are still very much needed." @default.
• W4248833643 created "2022-05-12" @default.
• W4248833643 creator A5033244606 @default.
• W4248833643 creator A5040303985 @default.
• W4248833643 creator A5073638566 @default.
• W4248833643 date "2009-01-01" @default.
• W4248833643 modified "2023-10-16" @default.
• W4248833643 title "Type 2 Diabetes" @default.
• W4248833643 cites W1502524639 @default.
• W4248833643 cites W1526927233 @default.
• W4248833643 cites W172609984 @default.
• W4248833643 cites W1752045965 @default.
• W4248833643 cites W1971056977 @default.
• W4248833643 cites W1980717583 @default.
• W4248833643 cites W1984297603 @default.
• W4248833643 cites W1987449176 @default.
• W4248833643 cites W1993119975 @default.
• W4248833643 cites W2000048524 @default.
• W4248833643 cites W2000634649 @default.
• W4248833643 cites W2021976026 @default.
• W4248833643 cites W2022939284 @default.
• W4248833643 cites W2027702390 @default.
• W4248833643 cites W2032048326 @default.
• W4248833643 cites W2034419419 @default.
• W4248833643 cites W2036939737 @default.
• W4248833643 cites W2044437167 @default.
• W4248833643 cites W2046645679 @default.
• W4248833643 cites W2047864863 @default.
• W4248833643 cites W2056312050 @default.
• W4248833643 cites W2061694846 @default.
• W4248833643 cites W2068326612 @default.
• W4248833643 cites W2069150029 @default.
• W4248833643 cites W2077149049 @default.
• W4248833643 cites W2078089300 @default.
• W4248833643 cites W2090609048 @default.
• W4248833643 cites W2090824142 @default.
• W4248833643 cites W2092509345 @default.
• W4248833643 cites W2094595851 @default.
• W4248833643 cites W2100800328 @default.
• W4248833643 cites W2106343349 @default.
• W4248833643 cites W2106603497 @default.
• W4248833643 cites W2106689948 @default.
• W4248833643 cites W2111152015 @default.
• W4248833643 cites W2111220320 @default.
• W4248833643 cites W2115607452 @default.
• W4248833643 cites W2123744385 @default.
• W4248833643 cites W2123946565 @default.
• W4248833643 cites W2126115073 @default.
• W4248833643 cites W2132594773 @default.
• W4248833643 cites W2137176029 @default.
• W4248833643 cites W2139634859 @default.
• W4248833643 cites W2144693872 @default.
• W4248833643 cites W2150388129 @default.
• W4248833643 cites W2153449155 @default.
• W4248833643 cites W2156988995 @default.
• W4248833643 cites W2158783782 @default.
• W4248833643 cites W2158822657 @default.
• W4248833643 cites W2159449551 @default.
• W4248833643 cites W2161392015 @default.
• W4248833643 cites W2168536185 @default.
• W4248833643 cites W2168825241 @default.
• W4248833643 cites W2170271198 @default.
• W4248833643 cites W2170378756 @default.
• W4248833643 cites W2171294019 @default.
• W4248833643 cites W2188846692 @default.
• W4248833643 cites W2331274940 @default.
• W4248833643 cites W2332951586 @default.
• W4248833643 cites W2337454357 @default.
• W4248833643 cites W2496975361 @default.
• W4248833643 cites W2769264260 @default.
• W4248833643 cites W4212827053 @default.
• W4248833643 cites W4213055016 @default.
• W4248833643 cites W4238251256 @default.
• W4248833643 cites W4241308027 @default.
• W4248833643 doi "https://doi.org/10.1007/978-1-60327-850-8_2" @default.
• W4248833643 hasPublicationYear "2009" @default.
• W4248833643 type Work @default.
• W4248833643 citedByCount "1" @default.
• W4248833643 countsByYear W42488336432012 @default.
• W4248833643 crossrefType "book-chapter" @default.
• W4248833643 hasAuthorship W4248833643A5033244606 @default.
• W4248833643 hasAuthorship W4248833643A5040303985 @default.
• W4248833643 hasAuthorship W4248833643A5073638566 @default.
• W4248833643 hasConcept C126322002 @default.
• W4248833643 hasConcept C134018914 @default.
• W4248833643 hasConcept C2777180221 @default.
• W4248833643 hasConcept C2779234561 @default.
• W4248833643 hasConcept C2779434492 @default.
• W4248833643 hasConcept C2780323712 @default.
• W4248833643 hasConcept C2780473172 @default.
• W4248833643 hasConcept C2780578515 @default.
• W4248833643 hasConcept C2780586474 @default.
• W4248833643 hasConcept C2781179581 @default.
• W4248833643 hasConcept C46973012 @default.
• W4248833643 hasConcept C511355011 @default.
• W4248833643 hasConcept C54355233 @default.
• W4248833643 hasConcept C544821477 @default.
• W4248833643 hasConcept C555293320 @default.

• next